30 Years – India’s Strategy Boutique
30 Years – India’s Strategy Boutique

Life Sciences (Pharma & Medtech)

Developing Value Proposition for AMR Mol Dx Panels

Back +

Client Challenge

The client, an Indian molecular diagnostics company, sought to assess the Indian market for introducing their Mol Dx test panels for Anti-Microbial Resistance (AMR). The focus was on developing a compelling value proposition for these panels.

Our Approach

To develop a value proposition for the client, UC adopted the following approach:

  • Market Research: Conducted thorough primary and secondary research to understand the current scenario of AMR diagnosis and treatment in India.
  • Value Analysis: Triangulated primary and secondary research to analyze the value proposition of the panels and establish their relevance in the Indian market.
  • Customer Segmentation: Assessed relevant customer segments/hospitals and gathered insights on their adoption favorability.
  • Positioning Strategy: Provided detailed recommendations for positioning the AMR panels in the diagnostic pathways followed by different tiers of hospitals.
  • Impact Analysis: Analyzed the impact on the total cost of care and average length of stay (ALOS) in both the current and future scenarios integrating the client’s panels.

Our Impact

The client received detailed insights into the relevance of their Mol Dx test panels in the Indian market and recommendations on how the introduction of their AMR panels can effectively reduce costs of care, ALOS, and the burden of medications.